Categories
Change Password!
Reset Password!
Glutathione supplementation improves fatty liver d...
Pioneering antidiabetic leads as first FDA-approve...
A novel press release by the FDA in Dec 2024 presented the approval of the trailblazing drug treatment - tirzepatide for managing obstructive sle...
Zinc eases menstrual pain: Just 7 mg/day provides...
For millions of women, primary dysmenorrhea (PD) or menstrual pain is more than just "period pain"—it’s a recurring battle...
Tech-driven counselling cuts pain and boosts well-...
Meichenbaum’s computer-based stress inoculation training (SIT) has proven highly effective in relieving pelvic pain, reducing anxiety and d...
Could myo-inositol improve IVF outcomes? Experts w...
A new position statement from leading reproductive health experts, including the Experts Group on Inositol in Basic and Clinical Research and on...
New guideline updates best practices for patch tes...
The European Society of Contact Dermatitis (ESCD) has released updated guidelines on diagnostic patch testing, offering a comprehensive, evidence...
Study confirms modified bismuth quadruple therapy...
In the face of rising Helicobacter pylori (H. pylori) elimination failure, a new systematic review and meta-analysis offers promising evidence th...
Low-dose ginger supplement improves asthma control...
In a new randomized trial, twice daily use of 1 g oral ginger ameliorated asthma control in mild-to-moderate asthmatics. The goal was to evaluate...
Dexmedetomidine vs. lorazepam: Which works better...
A randomized clinical trial sought to determine the efficacy and safety of intranasal dexmedetomidine (Dex) vs. oral lorazepam in patients experi...
Eat Your Greens! Brassicaceae vegetables may help...
Learned for their bioactive compounds and documented potential to decrease oxidative stress and inflammation, Brassicaceae vegetables (such as br...
Real-world data supports vildagliptin-metformin FD...
A multicenter post-marketing study portrayed the real-world effectiveness, safety, and tolerability of a fixed-dose combination (FDC) of vildagli...
Linzagolix provides long-term relief for heavy men...
A new analysis from the PRIMROSE 1 and 2 phase 3 trials confirms that oral linzagolix, administered once daily at 100 mg or 200 mg—with or...
Therapeutic role of melatonin in fibromyalgia: A s...
Melatonin—a hormone primarily implicated in sleep regulation—has emerged as a potential treatment to alleviate fibromyalgia-linked sy...
Psoriasis vulgaris as a potential risk factor for...
This cross-sectional study examined the prevalence of apical periodontitis (AP) and dental caries in individuals diagnosed with psoriasis vulgari...
Metabolic and hormonal predictors of NAFLD in obes...
Polycystic ovary syndrome (PCOS) is closely connected with non-alcoholic fatty liver disease (NAFLD), especially in overweight and obese individu...
Real-world data supports vildagliptin-metformin FD...
Linzagolix provides long-term relief for heavy men...
A new analysis from the PRIMROSE 1 and 2 phase 3 trials confirms that oral linzagolix, administered once daily at 100 mg or 200 mg—with or...
Clopidogrel vs. aspirin: Which is better for long-...
Clopidogrel monotherapy substantially reduced the risk of major cardiovascular events compared to aspirin in high-risk people who completed stand...
Targeted nerve freezing may lower phantom limb pai...
A systematic review issued in "Neurology" has found that cryoneurolysis—a minimally invasive technique that temporarily disables...
Most patients accept penicillin de-labelling after...
A new United Kingdom (UK)-based study from the ALABAMA trial reveals that most patients are open to having their penicillin allergy status remove...
Mometasone furoate + montelukast effectively relie...
A systematic review and meta-analysis of 5 randomized clinical trials (RCTs) shows that the mometasone furoate (MF) + montelukast provides consid...
Long-term clopidogrel boosts survival after limb r...
A large retrospective study reveals that patients with peripheral arterial disease (PAD) who received clopidogrel for more than 12 months followi...
Ciclopirox plus photodynamic therapy cures onychom...
As per the outcomes of a prospective case series published in "Journal of Clinical Medicine", combining ciclopirox 8% topical treatment...
Study compares tegoprazan vs. PPIs for erosive eso...
A systematic review and meta-analysis has revealed that tegoprazan, a novel potassium-competitive acid blocker (P-CAB), is as effective and safe...
Dupilumab shows comprehensive benefits in atopic d...
According to the findings of a systematic review and meta-analysis, dupilumab remarkably improves quality of life, psychological well-being, and...
